VITILIGO DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Vitiligo Drugs Market - Overview Global Vitiligo Drugs Market, by Drug Class (Calcineurin Inhibitors, Corticosteroids, and Psoralens), by Type (Segmental and Non-segmental), by Route of Administration (Oral and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 120.6 million in 2017, and is projected to exhibit a CAGR of 8.4% over the forecast period (2018–2026). Increasing demand for drugs for efficient treatment of vitiligo is expected to drive growth of the global vitiligo drugs market during the forecast period. Research institutes and manufacturers are focused on research and development of new drugs for the treatment of vitiligo in order to cater to increasing consumer demand. For instance, in June 2019, Incyte Corporation announced positive results from the phase 2 study of the Ruxolitinib cream, which is a non-steroidal, anti-inflammatory, JAK inhibitor therapy for patients with vitiligo. Similarly, in July 2019, the Defense Research and Development Organization (DRDO), India, announced a research for the development of a new herbal drug for the treatment of vitiligo. Furthermore, in 2018, Boston Pharmaceutical expanded its product pipeline by adding a topical formulation called GSK3183475 from GlaksoSmith Kline, a small molecule inhibitor used in the treatment of vitiligo and psoriasis, currently in phase 1 clinical trial.
Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/vitiligo-drugs-market-2447 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Browse 45 Market Data Tables and 38 Figures spread through 164 Pages and in-depth TOC on “Vitiligo Drugs Market”- Global Forecast to 2026 by Drug Class (Calcineurin Inhibitors, Corticosteroids, and Psoralens), by Type (Segmental and Non-segmental), by Route of Administration (Oral and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa). Key players in the market are focused on adopting collaboration and acquisition strategies to develop and commercialize novel vitiligo treatment drugs in order to expand their product portfolio. This in turn is expected to create conducive environment for growth of the market over the forecast period.
For instance, in October 2018, Boston Pharmaceutical entered into a licensing agreement with GlaxoSmithKline for the development and commercialization of phase 1 drug products for the treatment of vitiligo. Similarly, in December 2018, Incyte Corporation and Innovent Biologics, Inc. entered into a strategic licensing agreement for three clinical stage products in China. The product includes itacitinib (JAK1 inhibitor) in phase 2 clinical trials. Therefore, increasing research and development activities related to vitiligo drugs is expected to facilitate growth of the market over the forecast period. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2447 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Key Takeaways of the Global Vitiligo Drugs Market: The global vitiligo drugs market is expected to exhibit a CAGR of 8.4% over the forecast period, owing to factors such as increasing incidence of vitiligo and various government initiatives to support the treatment of the disease Among drug class, corticosteroids segment accounted for a major market share in 2018, as topical corticosteroids are first-choice of treatment against vitiligo Among route of administration, topical segment accounted for a major market share in 2018, owing to the launch and approval of novel topical medications for the management and treatment of vitiligo. For instance, in 2014, Dr. Reddy's Laboratories, a pharmaceutical company based in India, launched the Melgain lotion indicated for the treatment of vitiligo and other skin pigmentation disorders in India. Major players operating in the global vitiligo drugs market include, Dermavant Sciences, Inc., Incyte Corporation, Aclaris Therapeutics, Inc., Dr. Reddy’s Laboratories Ltd., Bristol - Myers Squibb, Pfizer, Inc., Clinuvel Pharmaceuticals Ltd., Applied Biology, Inc., and Boston Pharmaceuticals Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2447 Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry
Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved